Northwest Biotherapeutics Inc (NWBO): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Figures left out. The filed Shares Outstanding for the years ended 2019-12-31, 2021-12-31, 2023-12-31 are not shown: shares outstanding out of scale with weighted shares. That usually means the filing tagged the figure in the wrong unit.

1.56B

As of 2025-12-31

1.67B

As of 2026-06-30

+13.3%

3-year compound annual growth

+13.4%

5-year compound annual growth

2010-12-31 Shares Outstanding (shares) 2025-12-31

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	1.56B	+17.1%	2026-04-15, Balance as of period end
2024-12-31	1.33B	n/a	2026-04-15, Balance as of period end
No annual figure between 2022-12-31 and 2024-12-31.
2022-12-31	1.07B	n/a	2024-03-05, Balance as of period end
No annual figure between 2020-12-31 and 2022-12-31.
2020-12-31	829.60M	n/a	2022-03-01, Balance as of period end
No annual figure between 2018-12-31 and 2020-12-31.
2018-12-31	523.20M	+59.1%	2020-03-16, Balance as of period end
2017-12-31	328.90M	n/c	2019-04-02, Balance as of period end
2016-12-31	157.00M	+63.8%	2018-04-17, Balance as of period end
2015-12-31	95.86M	+39.0%	2017-04-17, Balance as of period end
2014-12-31	68.96M	n/c	2016-03-16, Balance as of period end
2013-12-31	45.67M	+85.1%	2015-03-17, Balance as of period end
2012-12-31	24.68M	n/c	2014-04-01, Balance as of period end
2011-12-31	9.33M	-87.2%	2013-04-08, Balance as of period end
2010-12-31	73.12M	n/a	2012-04-13, Balance as of period end